[
  {
    "ts": "2025-08-26T13:00:45+00:00",
    "headline": "Are Wall Street Analysts Predicting Quest Diagnostics Stock Will Climb or Sink?",
    "summary": "Quest Diagnostics has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.",
    "url": "https://www.barchart.com/story/news/34392899/are-wall-street-analysts-predicting-quest-diagnostics-stock-will-climb-or-sink",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "8cd96d46-a461-3756-9872-57c3d9aec58d",
      "content": {
        "id": "8cd96d46-a461-3756-9872-57c3d9aec58d",
        "contentType": "STORY",
        "title": "Are Wall Street Analysts Predicting Quest Diagnostics Stock Will Climb or Sink?",
        "description": "",
        "summary": "Quest Diagnostics has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.",
        "pubDate": "2025-08-26T13:00:45Z",
        "displayTime": "2025-08-26T13:00:45Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/cf9e80d918720712121d2641e3d89fd8",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "Quest Diagnostics, Inc_ logo on building-by Tada Images via Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5lknme7yrySg6FSZRgeeFg--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/barchart_com_477/cf9e80d918720712121d2641e3d89fd8.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Zq9jeVPBbTryyl7HEITAPA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/cf9e80d918720712121d2641e3d89fd8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/34392899/are-wall-street-analysts-predicting-quest-diagnostics-stock-will-climb-or-sink",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/wall-street-analysts-predicting-quest-130045392.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DGX"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-26T13:00:00+00:00",
    "headline": "Corewell Health and Quest Diagnostics to Enter into Joint Venture Providing Enhanced Laboratory Services in Michigan",
    "summary": "Corewell Health and Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, have signed a definitive agreement to enter into a joint venture to expand access to innovative, quality and affordable laboratory services in Michigan.",
    "url": "https://finance.yahoo.com/news/corewell-health-quest-diagnostics-enter-130000343.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "a3ee5099-febb-3244-bf27-f3b4dada4beb",
      "content": {
        "id": "a3ee5099-febb-3244-bf27-f3b4dada4beb",
        "contentType": "STORY",
        "title": "Corewell Health and Quest Diagnostics to Enter into Joint Venture Providing Enhanced Laboratory Services in Michigan",
        "description": "",
        "summary": "Corewell Health and Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, have signed a definitive agreement to enter into a joint venture to expand access to innovative, quality and affordable laboratory services in Michigan.",
        "pubDate": "2025-08-26T13:00:00Z",
        "displayTime": "2025-08-26T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/328ba769d21514205fa2226e0dacf99b",
          "originalWidth": 400,
          "originalHeight": 190,
          "caption": "Quest Diagnostics Incorporated logo. (PRNewsFoto/Quest Diagnostics Incorporated)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FuRCtrLWo1T4qYYDhuscJw--~B/aD0xOTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/328ba769d21514205fa2226e0dacf99b.cf.webp",
              "width": 400,
              "height": 190,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/L_XnLitlJHZ7Gn01q1kijg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/328ba769d21514205fa2226e0dacf99b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/corewell-health-quest-diagnostics-enter-130000343.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/corewell-health-quest-diagnostics-enter-130000343.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-26T10:38:50+00:00",
    "headline": "FDA grants breakthrough device designation for Quest Diagnostics’ MRD test",
    "summary": "The liquid biopsy test has been developed by experts in cancer genomics.",
    "url": "https://www.medicaldevice-network.com/news/fda-breakthrough-designation-quest/",
    "source": "Medical Device Network",
    "provider": "yfinance",
    "raw": {
      "id": "5684acb1-771a-36ed-b9eb-a5c1e4c2fa55",
      "content": {
        "id": "5684acb1-771a-36ed-b9eb-a5c1e4c2fa55",
        "contentType": "STORY",
        "title": "FDA grants breakthrough device designation for Quest Diagnostics’ MRD test",
        "description": "",
        "summary": "The liquid biopsy test has been developed by experts in cancer genomics.",
        "pubDate": "2025-08-26T10:38:50Z",
        "displayTime": "2025-08-26T10:38:50Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medical_device_network_744/5fdd16d0de9dedec2239fc5ea816d63f",
          "originalWidth": 1440,
          "originalHeight": 822,
          "caption": "The test offers a sensitive method for detecting minute quantities of ctDNA in the blood. Credit: National Cancer Institute on Unsplash.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/z3QxLmowOC..e7YgOR2p0w--~B/aD04MjI7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medical_device_network_744/5fdd16d0de9dedec2239fc5ea816d63f.cf.webp",
              "width": 1440,
              "height": 822,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DTSSoWY_af8SMOhTTxqfCg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medical_device_network_744/5fdd16d0de9dedec2239fc5ea816d63f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Medical Device Network",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medicaldevice-network.com/news/fda-breakthrough-designation-quest/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-grants-breakthrough-device-designation-103850097.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-08-26T10:00:00+00:00",
    "headline": "Tempus inks $81M Paige buyout to support AI model development",
    "summary": "CEO Eric Lefkofsky said that buying Paige “substantially accelerates” Tempus’ effort to build the largest foundation model in oncology.",
    "url": "https://www.medtechdive.com/news/tempus-paige-buyout-acquisition-ai/758589/",
    "source": "MedTech Dive",
    "provider": "yfinance",
    "raw": {
      "id": "d0b69255-fafb-38d2-adb9-69249714318c",
      "content": {
        "id": "d0b69255-fafb-38d2-adb9-69249714318c",
        "contentType": "STORY",
        "title": "Tempus inks $81M Paige buyout to support AI model development",
        "description": "",
        "summary": "CEO Eric Lefkofsky said that buying Paige “substantially accelerates” Tempus’ effort to build the largest foundation model in oncology.",
        "pubDate": "2025-08-26T10:00:00Z",
        "displayTime": "2025-08-26T10:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medtech_dive_335/5a2f50a74b9236ed5c226569d1a9813e",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "Paige received de novo clearance for its first product, Paige Prostate Detect, designed to help pathologist identify areas of tissue that are suspected of cancer.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LgQ5IRv3.XEOBpPSaL1bFQ--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medtech_dive_335/5a2f50a74b9236ed5c226569d1a9813e.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4ecsTL3ShjF.2WWz_iw.8Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medtech_dive_335/5a2f50a74b9236ed5c226569d1a9813e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MedTech Dive",
          "url": "https://medtechdive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medtechdive.com/news/tempus-paige-buyout-acquisition-ai/758589/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/tempus-inks-81m-paige-buyout-100000910.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TEM"
            },
            {
              "symbol": "PHIA.AS"
            },
            {
              "symbol": "DGX"
            },
            {
              "symbol": "MSFT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]